This is an offer from our trusted sponsors  Dear Investor, In October 2013, a scientist wrote three words down on a piece of paper. They were simple words. A five-year-old could say them. But these words hold the key to a new breakthrough the Economist says would be "A boon to humanity." And CNBC says, "Would help tens of millions of people." He began to tell fellow scientists the three words. And his ideas for them. He soon recruited a team that's been called "the best scientists on earth." Then he started telling investors about them. In May 2015 Fidelity Biosciences cut him a check for $217 million, along with an investor group. In August 2016, he told Jeff Bezos the three the words. He walked out with a check for $130 million. It took just over a year - 390 days - for his company to hit a $1 billion valuation. That's faster than any company in history, including Facebook. All because of three words. Words that all happen to start with the letter "B." [Discover the 3 words behind "the biggest drug ever" ]( How is that possible? It's because the three words hold the key to a new treatment Jim Cramer says would be "the biggest drug ever." A treatment that experts predict could help as many as 50 million people...and save the United States $20 trillion in medical costs. Any company that harnesses this treatment will thrive. Which is why a Big Pharma giant bought 11.2% of this small firm's stock last year. If you follow the lead of Bezos, Fidelity and the Big Pharma giant, you can lock in your stake in this firm today... And watch three words turn a $1,000 investment into more than $1.1 million. You have every right to be skeptical... But when I show you the three words and what they mean... You'll understand why so many people are rushing to back this visionary entrepreneur... And why The Wall Street Journal says, "The financial benefits would be massive." These three words could do more than just make you rich. They can change how we treat one of the cruelest diseases on earth. [Discover the 3 words behind "the biggest drug ever" ]( "The Buck Stops Here" [dylan jovine signature] Dylan Jovine
Chairman
Behind the Markets  Advertisement: This is a paid advertisement from a 3rd party advertiser, for a product or service that is not offered, recommended or endorsed by us and for which claims have not been independently verified. Content: All of the content on our website and in our emails is for informational and illustrative purposes only, and should not be construed as an offer, or solicitation of an offer to buy or sell securities. You should always consult with a licensed securities professional before purchasing or selling securities. 7322437 Canada (DBA as Financial Media Marketing) (collectively, the âCompanyâ or âweâ used herein) bears no responsibility or control over the content of the advertisement and/or the product or service offered. Results: Any results shown are strictly hypothetical, and were executed in simulated trading accounts. CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN. Earnings Disclaimer: Our website, blogs and emails use affiliate and advertising programs for monetization, which means when you open, read, click on ads or links, will result in a commission that is credited to our company. Compliance: All header and reply-to information is accurate; you may reply directly to this email or send your reply to the physical address or email listed below. Subject lines reflect the content of the email and the email is clearly identified as an advertisement. All opt-outs are automatically honored and managed by the system. When profiling a specific company / stock or publicly traded company: 7322437 Canada Inc (DBA as Financial Media Marketing) has been retained by a third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing, In exchange for such services we have or will receive cash compensation from the third party. Questions regarding this may be sent to admin@financialmediamarketing.com Any information regarding a company profiled or discussed on this website or email is provided from public sources. And we make no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Our Principals, employees or affiliates may have a position or effect transactions in the securities described herein (or options thereon) and /or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. Why are you receiving this email: You are receiving this email because you are subscribed and have requested to receive newsletters from Financial Media Marketing. Please note that Financial Media Marketing will deliver emails to your from several or all of our brands, which will show as different From Names in the emails you receive. You can [click here]( for a list of all our newsletter publications and From Names from which you will receive emails. Contact: For more information please contact us directly: 7322437 Canada Inc (Financial Media Marketing), 330 Av Avro, Pointe-Claire, QC, H9R 5W5. [Our privacy policy can be found here]( If you no longer want to receive any email from us, you can remove yourself from ALL newsletters using [this form](. Your unique contact ID 5f97275247bb03ed2b8b4567. [Today is]( Thursday. In order to unsubscribe from this mailing list, please click [here](